Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis

European Respiratory Journal

Volumn 13, Issue 4, 1999, Pages 733-738

  Ishii, Y ^a   Kitamura, S ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adhesion molecule; Bronchoalveolar lavage; Lymphocyte alveolitis; Radiation pneumonitis; Soluble intercellular adhesion molecule 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG CANCER; LUNG LAVAGE; LYMPHOCYTE COUNT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION PNEUMONIA;

BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY ALVEOLI; RADIATION PNEUMONITIS;

EID: 0032906595     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13d06.x     Document Type: Article

References (29)

1. Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977; 86: 81-92.
2. Roberts CM, Foulcher E, Zaunders JJ, et al. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 1993; 118: 696-700.
3. Cordier JF, Mornex JF, Lasne Y, et al. Bronchoalveolar lavage in radiation pneumonitis. Bull Eur Physiopathol Respir 1984; 20: 369-374.
4. Rosiello RA, Merrill WW, Rockwell S, et al. Radiation pneumonitis. Bronchoalveolar lavage assessment and modulation by a recombinant cytokine. Am Rev Respir Dis 1993; 148: 1671-1676.
5. Mark EJ. Lung Biopsy Interpretation. Baltimore, MD, Williams & Wilkins, 1984; pp. 73-74.
6. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-γ. Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
7. Marlin SD, Springer TA. Purified intercellular adhesion molecule 1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987; 51: 813-819.
8. Neumayer HP, Schulz TF, Peters JH, Dierich MP. Importance of ICAM-1 for accessory cell function of monocytic cells. Immunobiology 1990; 180: 458-466.
9. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting human T cells. J Immunol 1990; 144: 4579-4586.
10. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-1036.
11. Oppenheimer-Marks N, Davis LS, Bogue DT, Ramberg J, Lipsky PE. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991; 147: 2913-2921.
12. Hallahan D, Kuchibhotla J, Wyble C. Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. Cancer Res 1996; 56: 5150-5155.
13. Behrends U, Peter RU, Hintermeier-Knabe R, et al. Ionizing radiation induces human intercellular adhesion molecule-1 in vitro. J Invest Dermatol 1994; 103:726-730.
14. Kawana A, Shioya S, Katoh H, Tsuji C, Tsuda M, Ohta Y. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 on alveolar macrophages in the acute stage of radiation-induced lung injury in rats. Radiat Res 1997; 147: 431-436.
15. Hallahan DF, Virudachlam S. Intercellular adhesion molecule-1 knockout abrogates radiation induced pulmonary inflammation. Proc Natl Acad Sci USA 1997; 94: 6432-6437.
16. Nakayama Y, Makino S, Fukuda Y, Min K, Shimizu A, Ohsawa N. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiation Oncology Biol Phys 1996; 34: 459-467.
17. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.
18. Ishii Y, Kitamura S. Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis. Chest 1995; 107: 1636-1640.
19. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi JV, Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1991; 51: 5003-5005.
20. Altomonte M, Colizzi F, Esposito G, Maio M. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 1992; 327: 959.
21. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating intercellular adhesion molecule-1 in malignant diseases. Clin Exp Immunol 1991; 81: 3-8.
22. Adams DH, Mainolfi E, Burra P, et al. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 1992; 16: 810-814.
23. Hashimoto S, Imai K, Kobayashi T, et al. Elevated levels of soluble ICAM-1 in sera from patients with bronchial asthma. Allergy 1993; 48: 370-372.
24. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338: 83-84.
25. Roswit B, White DC. Severe radiation injury of the lung. Am J Roentgenol 1977; 129: 127-136.
26. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 1992; 102: 117-122.
27. Nash MC, Wade AM, Shah V, Dillon MJ. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule 1 (sVCAM-1) decrease with age. Clin Exp Immunol 1996; 103: 167-170.
28. Fraser RG, Pare JAP, Genereux GR. Diagnosis of Diseases of the Chest, 3rd Edn. Philadelphia, PA, WB. Saunders 1991; pp. 2551-2564.
29. Weber C, Erl W, Pietsch A, Strobel M, Ziegler-Heitbrock HLM, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994; 14: 1665-1673.